Cargando…
Measures of mortality in prostatic cancer.
The use of different expressions of mortality in prostate cancer can lead to difficulty in comparing reported data. We have used different measures of mortality in the same group of 438 patients presenting consecutively with histologically proven adenocarcinoma of the prostate, in order to assess th...
Autores principales: | Goodman, C. M., Ritchie, A. W., Chisholm, G. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971272/ https://www.ncbi.nlm.nih.gov/pubmed/2328216 |
Ejemplares similares
-
Successful external validation of a model to predict other cause mortality in localized prostate cancer
por: Kent, Matthew, et al.
Publicado: (2016) -
Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
por: Goodman, Oscar, et al.
Publicado: (2014) -
Production and response of a human prostatic cancer line to transforming growth factor-like molecules.
por: MacDonald, A., et al.
Publicado: (1990) -
Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.
por: Maddy, S. Q., et al.
Publicado: (1989) -
On the Black–White Disparity in Prostate Cancer Mortality
por: Brawley, Otis W, et al.
Publicado: (2021)